Step 1: Understanding the Concept:
Marine organisms produce unique bioactive compounds with potential pharmaceutical, nutraceutical, and industrial applications.
Fisheries research institutes in India isolate these compounds to develop commercial products, which are registered under specific trademarks.
Step 2: Detailed Explanation:
CADALMIN is the registered trademark of the ICAR-Central Marine Fisheries Research Institute (ICAR-CMFRI), located in Cochin, Kerala.
ICAR-CMFRI has utilized this brand name to commercialize a series of marine-derived nutraceuticals and bioactive products developed by its scientists, including:
- Cadalmin Green Mussel Extract (Cadalmin\(^{\text{TM}}\) GMe): A product derived from green mussels used to relieve joint pain and arthritis.
- Cadalmin Antidiabetic Extract (Cadalmin\(^{\text{TM}}\) ADt): Formulated from marine macroalgae to help manage Type-2 diabetes.
- Cadalmin Anti-hypercholesterolemic Extract (Cadalmin\(^{\text{TM}}\) ACe): Developed from seaweeds to help lower cholesterol.
These products demonstrate CMFRI's work in utilizing marine resources for human health, protected under the proprietary trademark CADALMIN.
Step 4: Final Answer:
‘CADALMIN’ is the registered trademark of ICAR-CMFRI, which corresponds to Option (A).